Close

Clinical Trials

AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio Including Extensive Programs in China

Median Technologies, The Imaging Phenomics Company and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and delivery of medical images and ancillary data in support current and future clinical trials and...

Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with B-TRIALS in Chile.

The Chilean company B-TRIALS, a specialist in providing tools and solutions in the health area, will be responsible for the expansion of Clinerion in Chile. This will give patients in Chile quicker and better access to innovative medical treatments...

SpringWorks and GSK sign clinical trial collaboration agreement

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma. Under the clinical trial collaboration agreement, GSK will sponsor and conduct an adaptive Phase...

Clinerion partners with the Czech Clinical Research Institute to bring its services to patients in the Czech Republic and Slovakia

The Czech Clinical Research Institute (CCRI) will support patients and physicians in the Czech Republic and Slovakia in accessing innovative treatments by expanding Clinerion’s hospital and patient coverage into those countries. CCRI will also accelerate the...

Data Collection in Phase II-III Clinical Research – It is Ripe for Disruption?

Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems. Industry leaders, such as Janet Woodcock, of the FDA's Centre for...

The Essential Role of Interactive Response Technology (IRT) in Clinical Trial Supply

Increasingly elaborate international clinical trials are demanding a smarter, streamlined approach from supply partners and better collaboration with sponsors. In this environment, Interactive Response Technology (IRT) systems have been a staple and a powerful, practical tool for optimizing a product’s...

Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine

Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC) Detailing the efficacy of the product in preventing invasive disease and pneumonia caused by Streptococcus pneumoniae at the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read